Virtual patient trials of a multi-input stochastic model for tight glycaemic control using insulin sensitivity and blood glucose data

ConclusionsThe 3D stochastic model provided greater personalisation and better realised STAR’s design philosophy of minimising hyperglycaemic events for an acceptable clinical risk of 5.0 % BG < 4.4 mmol/L. Thus, this model could provide better clinical conformity to design targets if implemented within the STAR protocol.
Source: Biomedical Signal Processing and Control - Category: Biomedical Science Source Type: research